Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06865222 · ClinicalTrials.gov registry record · NA
Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation
A NA study of Post COVID-19 Condition, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06865222 is a NA study of Post COVID-19 Condition that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06865222, a NA study of Post COVID-19 Condition, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).
Conditions Studied
Interventions
- PROCEDURE Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks
- PROCEDURE Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-22 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06865222
The ClinicalTrials.gov registry entry for NCT06865222 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post COVID-19 Condition appearing as the primary indexed condition, and to 2 interventions - of which Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks is the first listed.
NCT06865222 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06865222 about?
NCT06865222 is a clinical study titled "Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation". The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).
What is the current status of trial NCT06865222?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-22. Estimated completion is 2027-04.
What conditions does trial NCT06865222 study?
This clinical trial studies the following conditions: Post COVID-19 Condition.
What interventions are being tested in trial NCT06865222?
The interventions under investigation include: Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks (PROCEDURE), Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 4 weeks (PROCEDURE).
Who is sponsoring clinical trial NCT06865222?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06865222 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post COVID-19 Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
ACTIVE NOT RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.